[Ip-health] Re: [e-drug] MSF Workshop 30 Sept 2009 "medicines in transit atcustoms..":

[Sefali]

How will people from Africa get the outcome. We are very much interested.
sefali
National Drug Service Organization

----- Original Message -----
From: "Alexandra HEUMBER" <Alexandra.HEUMBER@brussels.msf.org>
To: <ip-health@lists.essential.org>; <e-drug@healthnet.org>
Sent: Monday, September 21, 2009 11:54 AM
Subject: [e-drug] MSF Workshop 30 Sept 2009 "medicines in transit
atcustoms..":


> E-DRUG: MSF Workshop 30 Sept 2009 "..medicines in transit at customs.."
> ---------------------------------------------------------------
> To confirm attendance, please send an email to Ms Mai Do: mdo@msf.org,
> You will need to register before 23 September 2009 to attend the WTO
> Public Forum at:
> https://meetings.wto.org/Forums/Registrant/SymposiumRegistration.aspx?Language=E
>
> INVITATION
>
> Medecins Sans Frontieres workshop at the World Trade Organization Public
> Forum
>
> Controversy at customs - the detention of medicines in transit:
> what impact on access to medicines?
>
> Wednesday 30 September 2009, 14:15 to 16:15
> WTO building, Room A
>
> Recent detainments by European Union countries' customs authorities of
> legitimate generic medicines transiting through the EU on their way to
> developing countries, have attracted the criticism of WTO Member States
> and civil society alike.  Conducted on the grounds of suspected patent or
> trademark infringements, the detentions intercept legitimate trade, and
> could impact the affordability and availability of generic medicines in
> developing countries.
>
> The incidents highlight questions about the compatibility of EC customs
> Regulation 1383/2003 and proposed provisions in free trade agreements with
> WTO Member States obligations under the TRIPS Agreement,  in particular
> the Doha  Declaration on the TRIPS Agreement and Public Health, and  in
> relation to GATT.
>
> MSF will explore the legal and practical effect of  these  issues for
> access to medicines in developing countries, in a roundtable  with
> academics, member states, suppliers of  medicines, civil society
> organisations and representatives of the pharmaceutical industry.
>
> Introduction
> Chair : Michelle Childs, Policy & Advocacy Director, MSF Campaign for
> Access to Essential Medicines
>
> Panel of  speakers
> Prof Carlos Correa, University of Buenos Aires
> Sunjay Sudhir, Counsellor, Permanent Mission of India to WTO
> Sergio Balibrea, Counsellor, Delegation of the European Commission to the
> International Organisations in Geneva
> Amb. Dr. Tom Mboya Okeyo, Ambassador/Deputy Permanent Representative of
> Kenya
> Jose Estanislau do Amaral Souza Neto, Counsellor, Permanent mission of
> Brazil to WTO
>
> Panel of respondents
> Arnout Gieske, Lawyer
> Edwin de Voogd,  Managing Director, IDA Foundation
> Representative of the pharmaceutical industry, tbc
> Niccolo Rinaldi, Member of the European Parliament
> Antony Taubman, Director, Intellectual Property Division, World Trade
> Organization
>
> Discussion & questions open to the floor
>
> To confirm attendance, please send an email to Ms Mai Do: mdo@msf.org,
> You will need to register before 23 September 2009 to attend the WTO
> Public Forum at:
> https://meetings.wto.org/Forums/Registrant/SymposiumRegistration.aspx?Language=E
>
> Alexandra HEUMBER <Alexandra.HEUMBER@brussels.msf.org>
> _______________________________________________
> Post message: e-drug@healthnet.org
> Subscribe: e-drug-join@healthnet.org
> Unsubscribe: e-drug-leave@healthnet.org
> Help: e-drug-owner@healthnet.org
> Info & archives: http://list.healthnet.org/mailman/listinfo/e-drug